CARDIOMEDICALE: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CARDIOMEDICALE
Largest movements
- Current investments +€350,000
new in 2025: €350,000
- Cash -€222,140
down €222,140 (-54.9%), from €404,583 to €182,443
mainly Current investments (-€350,000) and Investment in fixed assets (net) (-€10,734)
- Tangible fixed assets -€37,638
down €37,638 (-8.9%), from €423,485 to €385,847
of which Furniture and vehicles: -€19,717
- Receivables within one year -€22,601
down €22,601 (-53.9%), from €41,937 to €19,336
of which Trade receivables: -€23,160
- Reserves +€84,000
up €84,000 (+10.7%), from €786,085 to €870,085
- Debts after one year -€10,619
no longer reported in 2025 (was €10,619)
- Gross operating margin -€68,973
down €68,973 (-24.9%), from €276,744 to €207,771
- Taxes -€13,778
down €13,778 (-23.8%), from €57,829 to €44,051
- Financial charges -€7,866
down €7,866 (-79.7%), from €9,873 to €2,007
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €875,149 | €947,114 | +€71,966 | +8.2% |
| Fixed assets | 21/28 | €423,534 | €385,896 | -€37,638 | -8.9% |
| Tangible fixed assets | 22/27 | €423,485 | €385,847 | -€37,638 | -8.9% |
| Land and buildings | 22 | €330,175 | €320,356 | -€9,819 | -3.0% |
| Plant, machinery and equipment | 23 | €30,921 | €22,820 | -€8,102 | -26.2% |
| Furniture and vehicles | 24 | €62,388 | €42,671 | -€19,717 | -31.6% |
| Financial fixed assets | 28 | €50 | €50 | = | 0.0% |
| Current assets | 29/58 | €451,614 | €561,218 | +€109,604 | +24.3% |
| Amounts receivable within one year | 40/41 | €41,937 | €19,336 | -€22,601 | -53.9% |
| Trade receivables | 40 | €41,937 | €18,777 | -€23,160 | -55.2% |
| Other amounts receivable | 41 | - | €559 | +€559 | |
| Current investments | 50/53 | - | €350,000 | +€350,000 | |
| Cash at bank and in hand | 54/58 | €404,583 | €182,443 | -€222,140 | -54.9% |
| Deferred charges and accrued income | 490/1 | €5,095 | €9,440 | +€4,345 | +85.3% |
| Total equity and liabilities | 10/49 | €875,149 | €947,114 | +€71,966 | +8.2% |
| Equity | 10/15 | €798,675 | €882,634 | +€83,959 | +10.5% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €786,085 | €870,085 | +€84,000 | +10.7% |
| Distributable reserves | 133 | €786,085 | €870,085 | +€84,000 | +10.7% |
| Profit (loss) carried forward | 14 | €190 | €149 | -€41 | -21.5% |
| Amounts payable | 17/49 | €76,473 | €64,480 | -€11,993 | -15.7% |
| Amounts payable after more than one year | 17 | €10,619 | - | -€10,619 | |
| Financial debts | 170/4 | €10,619 | - | -€10,619 | |
| Amounts payable within one year | 42/48 | €64,759 | €62,333 | -€2,426 | -3.7% |
| Current portion of amounts payable after more than one year | 42 | €15,787 | €10,619 | -€5,168 | -32.7% |
| Financial debts | 43 | - | €8,333 | +€8,333 | |
| Credit institutions | 430/8 | - | €8,333 | +€8,333 | |
| Trade debts | 44 | €3,968 | €3,024 | -€945 | -23.8% |
| Suppliers | 440/4 | €3,968 | €3,024 | -€945 | -23.8% |
| Taxes, remuneration and social security | 45 | €30,273 | €22,656 | -€7,617 | -25.2% |
| Taxes | 450/3 | €25,566 | €17,831 | -€7,734 | -30.3% |
| Remuneration and social security | 454/9 | €4,707 | €4,825 | +€118 | +2.5% |
| Other amounts payable | 47/48 | €14,731 | €17,700 | +€2,969 | +20.2% |
| Accrued charges and deferred income | 492/3 | €1,095 | €2,147 | +€1,052 | +96.1% |
| Remuneration, social security and pensions | 62 | €25,179 | €27,045 | +€1,866 | +7.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €46,199 | €48,372 | +€2,173 | +4.7% |
| Other operating charges | 640/8 | €4,825 | €5,568 | +€743 | +15.4% |
| Non-recurring operating charges | 66A | €147 | - | -€147 | |
| Gross operating margin | 9900 | €276,744 | €207,771 | -€68,973 | -24.9% |
| Operating profit (loss) | 9901 | €200,395 | €126,786 | -€73,609 | -36.7% |
| Financial income | 75/76B | €1,323 | €4,090 | +€2,767 | +209.1% |
| Recurring financial income | 75 | €1,323 | €4,090 | +€2,767 | +209.1% |
| Financial charges | 65/66B | €9,873 | €2,007 | -€7,866 | -79.7% |
| Recurring financial charges | 65 | €9,873 | €2,007 | -€7,866 | -79.7% |
| Profit (loss) for the period before taxes | 9903 | €191,846 | €128,869 | -€62,977 | -32.8% |
| Income taxes | 67/77 | €57,829 | €44,051 | -€13,778 | -23.8% |
| Profit (loss) for the period | 9904 | €134,017 | €84,818 | -€49,199 | -36.7% |
| Profit (loss) for the period to be appropriated | 9905 | €134,017 | €84,818 | -€49,199 | -36.7% |
Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.